Figure 1.
![Figure 1. NY-ESO-1 gene expression. Gene expression profiling shows that NY-ESO-1 is expressed at increased frequency in patients with abnormal cytogenetics (a positive score is more than mean + 3 SD [90] of the GEP score of normal human PCs). SMM indicates smoldering MM.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/105/10/10.1182_blood-2004-09-3707/6/zh80100578580001.jpeg?Expires=1722778643&Signature=kEcTCFgY0qtrvsjy3PXeFQjs0v5XXcAikM99UhF-klgOZlcE9wI-r~mQSEb3kNSoDzMei7hmqzrEKJr9szU5nph0ob5Q2WaQjptFpDbsEWZOWT6jxNWdX3pvPcWRxZmZbHSAM-7m9SEa9qqRRT54f~f6CcUUlc42TXttlCxAWA8-mDJNgsY~19Un26lGdArwu85p5AOFPvVT5vG-yB5iq7gTXwrVo8zF-CzXm3n-EDeed~p6emNpW6sxVX~HjVUMz2vEtJe1QrXdsbWE03oVsP2CWikBTJ478S4kPl2-6xR9lUUv50udazY8sb1ZpVDkWJXzHm8iiBuBBLummjUchQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
NY-ESO-1 gene expression. Gene expression profiling shows that NY-ESO-1 is expressed at increased frequency in patients with abnormal cytogenetics (a positive score is more than mean + 3 SD [90] of the GEP score of normal human PCs). SMM indicates smoldering MM.
